All News

Members of the International Academy of Compounding Pharmacists (IACP) have elected pharmacist Dale Coker as their president.

At least two U.S. Senators believe so and have once again introduced legislation that would allow Americans to import medicines from Canada.

Oseltamivir, an antiviral agent for the treatment of influenza, should be started within 48 hours of symptom onset for most hospitalized patients and outpatients who are suspected of H1N1 or other strains of the flu, according to a recent report in the American Journal of Health-System Pharmacy.

Tops Friendly Markets in Williamsville, N.Y., is closing pharmacy departments in 27 of its 162 stores later this month. Instead of pharmacies, Tops will add more fresh food, deli and health and beauty care products. The stores themselves will remain open.

Alasdair Trotter, a principal at Innosight, explains disruptive innovations and how companies such as Walgreens, CVS, and others are using it to drive revenues.

A skin patch that may end up replacing needle sticks is being tested at U.C. San Diego.

FDA is seeking to learn how these Wallcur products, which are not sterile and should not be injected in humans or animals, entered the supply chain.

Topical treatment with vitamin D analogs and corticosteroids is the mainstay of first-line therapy for patients with localized psoriasis.

A group representing the nation’s governors has endorsed provider status for pharmacists as a way to improve medical outcomes and lower healthcare costs.

Calvin H. Knowlton, BS Pharm, MDiv, PhD, has been named this year’s Remington Honor Medal award winner and will be recognized next month at the American Pharmacists Association (APhA) annual meeting and exposition in San Diego.

An administrative hearing for a fired pharmacist has provided an eye-opening look into the workloads and the lack of accuracy standards for pharmacists working at Veterans Administration facilities in New Jersey.

For some pharmacists, leaving behind corporate constraints can be the start of something big.

Which comes first, diabetes or depression? While the connection is recognized, the answer is not yet certain.

Agency will use guidance in 2015 to address “key policy issues.”

In a world where insurance plans now fight for Star Ratings, why do we have a system that obstructs patients' efforts to obtain routine maintenance medications?

A Danish study of 150,900 patients found that the risk of serious bleeding doubled when patients were treated with NSAIDs.

Pharmacists face changes as the profession continues to redefine itself, but for most, the money's still good.

New OTC products offer several approaches to symptom relief.

Blister packs, close follow-up, and tight pharmacy planning are features of the new model.

What is it like to care for patients with Ebola? Clinical pharmacists share what they’ve learned.

What should pharmacies do to keep patient data and credit- and debit-card information secure? Start with these steps.

New drugs, new generics, new OTC

Let this be the year you do something for the cause.

Letters, e-mails, posts, and comments from readers of Drug Topics

That’s the assertion a Philadelphia-area pharmacist is making in a federal class action suit filed recently at the U.S. District Court for the Eastern District of Pennsylvania.

The factor Xa inhibitor edoxaban (Savaysa, Daiichi Sankyo) has been approved by FDA to lower the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation (AF), according to a January 8 announcement.

Prosecutors seized $18 million from accounts linked to the owners of the defunct New England Compounding Center, whose tainted products led to the 2012 meningitis outbreak that killed at least 64 people and sickened about 750.